NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Illumigyn

Illumigyn

Private
IsraelHealthcare & Life Scienceshttps://www.illumigyn.com/

Last Round

Early Funding

Nov 3, 2021

Total Funding Raised

$38M

Company Overview

Illumigyn is a health tech company which has developed the Gynescope, an FDA-cleared remote gynecological imaging platform designed to improve diagnostic accuracy for women's health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Telemedicine, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

femtechtelehealthtelemedicineremote diagnosiscervical cancer screeninggynecological imagingdigital colposcopymedical devicewomen's healthmedical imagingcloud platformAI clinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Illumigyn Comparables

Compare Illumigyn with similar companies based on industry and business-model similarity.

Illumigyn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Illumigyn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingNov 3, 2021
SeedJun 9, 2016
View all Funding Rounds

Illumigyn Investors

Notable investors and investment history

Illumigyn investors
InvestorRounds
Yozma Group KoreaEarly Funding
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 3, 2021

    $33M raised with Yozma Group Korea and Ubicom Holdings leading.

  • Jun 9, 2016

    Raised $5M with investors Ariel Katz and Ran Poliakine

View all signals

Illumigyn Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Illumigyn Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Illumigyn's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range17
Year Founded2012
Last FundingNov 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.